Alberta Investment Management Corp (AIMCo)’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-200,000	Closed	-$1.66M	–	1060
2023 Q3	$1.66M	Hold	200,000	–	–	0.02%	497
2023 Q2	$2.07M	Hold	200,000	–	–	0.02%	533
2023 Q1	$2.03M	Hold	200,000	–	–	0.02%	551
2022 Q4	$1.99M	Hold	200,000	–	–	0.02%	638
2022 Q3	$1.95M	Hold	200,000	–	–	0.02%	730
2022 Q2	$1.94M	Hold	200,000	–	–	0.01%	731
2022 Q1	$1.94M	Buy	+200,000	New	+$1.94M	0.01%	789
2021 Q4	–	Sell	-200,000	Closed	-$1.94M	–	1038
2021 Q3	$1.94M	Buy	+200,000	New	+$1.95M	0.02%	644

Other funds holding NKGN

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

UOC

University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s NKGN Position: Q4 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q4 2023, closing a stake of 200,000 shares — an estimated $1.66M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in NKGN in Q3 2021 and held it in 8 quarters. The position peaked at $2.07M in Q2 2023. 9 funds tracked by Wall St. Rank hold NKGN as of Q4 2023.

Alberta Investment Management Corp (AIMCo) reported no remaining NKGen Biotech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 200,000 NKGen Biotech, Inc. Common Stock shares in Q4 2023, an estimated $1.66M.
Alberta Investment Management Corp (AIMCo) first reported a position in NKGen Biotech, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Alberta Investment Management Corp (AIMCo)'s NKGen Biotech, Inc. Common Stock position peaked at $2.07M in Q2 2023.
9 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q4 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2023, filed 12 Feb 2024.